NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
出版年份 2022 全文链接
标题
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
作者
关键词
-
出版物
Diabetology & Metabolic Syndrome
Volume 14, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-03
DOI
10.1186/s13098-022-00837-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus
- (2022) Liying Mu et al. Diabetology & Metabolic Syndrome
- Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
- (2021) Suriya Prausmüller et al. Cardiovascular Diabetology
- Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study
- (2021) Hui-Hui Liu et al. Cardiovascular Diabetology
- NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial
- (2021) Magnus O. Wijkman et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
- (2021) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis
- (2021) Kailash N. Pandey Frontiers in Physiology
- Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality
- (2021) Frederik H. Verbrugge et al. EUROPEAN HEART JOURNAL
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
- (2020) Mark C. Petrie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE)
- (2020) Atsushi Tanaka et al. ESC Heart Failure
- The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes
- (2020) Roni Nielsen et al. DIABETES OBESITY & METABOLISM
- Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications
- (2020) Anna Birukov et al. DIABETES CARE
- NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
- (2020) Marcus V. B. Malachias et al. Journal of the American Heart Association
- NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?
- (2020) Matthew A. Cavender et al. DIABETES CARE
- C-type natriuretic peptide co-ordinates cardiac structure and function
- (2019) Amie J Moyes et al. EUROPEAN HEART JOURNAL
- Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
- (2019) Yechen Han et al. Cardiovascular Diabetology
- Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
- (2019) Michael E. Nassif et al. CIRCULATION
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- NT-proBNP predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk
- (2018) Nienke M.A. Idzerda et al. DIABETES OBESITY & METABOLISM
- Atrial and brain natriuretic peptides: Hormones secreted from the heart
- (2018) Yasuaki Nakagawa et al. PEPTIDES
- Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
- (2018) Fumitaka Soga et al. Cardiovascular Diabetology
- Snake Venom Peptides: Tools of Biodiscovery
- (2018) Aisha Munawar et al. Toxins
- Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
- (2017) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells
- (2017) Ramona Al-Zoairy et al. Diabetology & Metabolic Syndrome
- Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
- (2017) Emil Wolsk et al. Journal of the American Heart Association
- Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
- (2016) Mauro Gori et al. DIABETES CARE
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
- (2016) Peter Willeit et al. Lancet Diabetes & Endocrinology
- Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
- (2015) Bernt Johan von Scholten et al. Cardiovascular Diabetology
- Identifying Novel Biomarkers for Cardiovascular Events or Death in People With DysglycemiaClinical Perspective
- (2015) Hertzel C. Gerstein et al. CIRCULATION
- Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
- (2015) Helen C. Looker et al. DIABETOLOGIA
- Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
- (2015) Risto Kerkelä et al. Journal of the American Heart Association
- Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
- (2015) D. K. Gupta et al. Journal of the American Heart Association
- Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients
- (2014) Chun-Jun Li et al. Cardiovascular Diabetology
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes
- (2013) M Rosiak et al. Advances in Medical Sciences
- NH 2 -Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
- (2013) Mariana Lazo et al. DIABETES
- N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes
- (2013) Graziella Bruno et al. DIABETES CARE
- The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes
- (2013) Graham S. Hillis et al. DIABETES CARE
- PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)
- (2013) Martin Huelsmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
- (2013) Anna Licata et al. PLoS One
- Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)
- (2011) John J.V. McMurray et al. AMERICAN HEART JOURNAL
- Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
- (2011) Akshay S. Desai et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
- (2011) Martin Andreas et al. Cardiovascular Diabetology
- The paradox of low BNP levels in obesity
- (2011) Aldo Clerico et al. HEART FAILURE REVIEWS
- Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmö Diet and Cancer Study
- (2011) Martin Magnusson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study
- (2010) A. P. Kengne et al. DIABETOLOGIA
- NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients
- (2009) Jacobijne J. Wiersma et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions - a systematic review
- (2009) A. M. R. Beleigoli et al. Obesity Reviews
- Níveis séricos de NT pro-BNP: relação com função sistólica e diastólica nas miocardiopatias e pericardiopatias
- (2008) Charles Mady et al. Arquivos Brasileiros de Cardiologia
- Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction
- (2008) Konstantinos P. Letsas et al. Clinical Research in Cardiology
- NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
- (2008) M. Huelsmann et al. EUROPEAN HEART JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started